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Synchronous double primary cancers associated with a 
choledochal cyst and anomalous pancreaticobiliary 
ductal union
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A 60-year-old female was admitted with epigastric pain lasting a month. Preoperative diagnosis was choledochal cyst with 
anomalous pancreaticobiliaryductal union (APBDU), C-P type. A papillary mass measuring 2.5 × 1.9 cm was found adjacent 
to the pancreaticocholedochal junction. Gallbladder (GB) cancer was also observed. Pyloric-preserving pancreatico-
duodenectomy (PPPD) was performed. The patient received adjuvant chemotherapy/radiation therapy on the tumor bed. 
The gallbladder cancer showed serosal invasion, while the bile duct cancer extended into the pancreas. Although common 
bile duct (CBD) cancer lesion showed focally positive for p53 and the gallbladder cancer lesion showed negative for p53, the 
Ki-67 labeling index of the CBD cancer and GB cancer were about 10% and 30%, respectively. Nine months after curative re-
section, a stricture on the subhepatic colon developed due to adjuvant radiation therapy. Localized peritoneal seedings were 
incidentally found during a right hemicolectomy. The patient underwent chemotherapy and had no evidence of tumor re-
currence for two years after PPPD.
Key Words: Choledochal cyst, Gallbladder neoplsms, Bile duct neoplasms, Synchronous multiple primary neoplasms
INTRODUCTION
In anomalous pancreaticobiliary ductal union (APBDU), 
the common channel is abnormally long and the con-
nection between the choledochus and pancreatic duct is 
outside of the duodenal wall [1]. This congenital disorder 
is frequently associated with choledochal cysts, another 
congenital condition consisting of localized or diffused di-
latation of the biliary tract [1]. Moreover, APBDU are 
prone to have benign as well as malignant complications 
including carcinoma of biliary tract [2].
Although several cases of single carcinoma in the biliary 
tract associated with APBDU have been reported, syn-
chronous double cancer is very rare [3]. We describe here 
a case of a choledochal cyst combined with APBDU that 
was first detected in a patient in her sixties as a double pri-
mary cancer of the gallbladder and CBD.
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Fig. 1. Magnetic resonance cholan-
giopancreatography (MRCP) image 
including vertical and horizontal 
sections. MRCP shows fusiform 
cystic changes involving the entire 
common bile duct and hilar bile duct 
compatible with a choledochal cyst 
(type Ⅰa) associated with the long 
common channel of the pancrea-
ticobiliary junction (C-P type). Irre-
gular wall thickening at the fundus 
and body of the gallbladder was 
seen. A 2.5 × 1.9 cm mass is also seen 
around the pancreaticobiliary junc-
tion. 
Fig. 2. Specimens from patient 
before and after fixation. The com-
mon bile duct (CBD) is markedly 
dilated, measuring 7 cm in inner 
circumference and 6.5 cm in length. 
Opening along the CBD revealed an 
ill-defined mass measuring 2 × 1.5 
cm. The gallbladder shows an 
ill-defined thickened wall area in the 
fundus measuring 3 × 3 cm. GB, 
gallbladder.
CASE REPORT
A 60-year-old female was admitted with a one month 
history of epigastric pain. Her medical records indicated 
she had taken medication for hypertension. Upon admit-
tance, right upper quardrant pain were found and the oth-
er symptoms including fever and weight loss were absent. 
On abdominal physical examination, no palpable mass or 
tenderness was discovered. Laboratory results revealed a 
total bilirubin level of 1.2 mg/dL, alanine aminotrans-
ferase of 201 IU/L, aspartate aminotransferase of 318 IU/L, 
and alkaline phosphatase of 126 IU/L. The levels of tumor 
markers carcinoembryonic antigen and carbohydrate an-
tigen 19-9 were 6.69 ng/mL and 0.1 U/mL, respectively. 
Magnetic resonance imaging and magnetic resonance 
cholangiopancreatico-graphy identified a choledochal 
cyst with APBDU, choledocho-pancreatic (C-P) type. An 
irregular-shaped papillary mass measuring 2.5 × 1.9 cm 
was found adjacent to the pancreaticocholedochal junc-
tion with pancreatic invasion and the irregular wall thick-
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Fig. 3. Hematoxylin & Eosin stain image of tumor. Tumor shows polypoid growth into the common bile duct (CBD) lumen with pancreatic 
invasion. (H&E; A, ×40; B, ×100). Adenocarcinoma of the gallbladder invaded fibromuscular connective tissue (H&E; C, ×40; D, ×100).
ening at the fundus and body of gallbladder was also seen. 
There was no lymph node enlargement or distant meta-
stasis (Fig. 1).     
Pylorus preserving pancreaticoduodenectomy (PPPD) 
was performed without additional hepatic resection. The 
proximal resection margin was at the level of the common 
hepatic duct bifurcation. Lymph node dissection was per-
formed around the hepatoduodenal ligament, common 
hepatic artery, celiac axis, and paraaortic area. 
On pathologic evaluation, the CBD was markedly di-
lated, measuring 7 cm in inner circumference and 6.5 cm in 
length. Upon opening, we found an ill-defined yellowish 
tan solid mass abutting on the ampulla of Vater, measur-
ing 2 × 1.5 × 1.5 cm. The gallbladder showed an ill-defined 
thickened wall area in the fundus, measuring 3 × 3 cm (Fig. 
2). Microscopic examination revealed moderately-differ-
entiated adenocarcinoma of the CBD with extension to the 
pancreatic head and moderately-differentiated adenocar-
cinoma of the gallbladder with extension to the serosa 
(Fig. 3). Only one regional node was involved by the tumor 
out of a total of 27 resected lymph nodes. There is no K-ras 
mutation on codon 12 and 13 in both gallbladder and CBD 
cancer lesions. In immunohistochemical staining with p53 
and Ki-67, although CBD cancer lesion showed focally 
positive for p53 and the gallbladder (GB) cancer lesion 
showed negative for p53, the Ki-67 labeling index of the 
CBD cancer and GB cancer were about 10% and 30%, re-
spectively (Fig. 4). 
After an uneventful postoperative course, the patient 
received adjuvant chemotherapy with cisplatin, tega-
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Fig. 4. Immunostaining of tumor. p53 and Ki-67 immunostaining (×100; A, B, common bile duct cancer; C, D, gallbladder cancer) and K-ras 
mutation analysis (E). 
fur-uracil (UFT), and radiation therapy on the tumor bed 
of the gallbladder with 5,040 cGy. Nine months after cura-
tive resection, a stricture developed on the subhepatic co-
lon due to adjuvant radiation therapy (Fig. 5). Localized 
peritoneal seedings were incidentally found during right 
hemicolectomy. The patient underwent chemotherapy-
with 5FU, Leucovorin and oxaliplatin 6 times. There is no 
evidence of tumor recurrence for 29 months after Rt. hemi-
colectomy with chemotherapy. 
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Fig. 5. Images of computed tomo-
graphy (CT), positron emission 
tomography (PET), colonoscopy 
and gross specimen for a com-
plication caused by adjuvant radia-
tion therapy. A stricture is shown on 
the subhepatic colon. (A, CT; B, PET; 
C, colonoscopy; D, gross specimen).
DISCUSSION
The mode of anomalous union is classified into two 
types: the pancreatico-choledochal (P-C) type, in which 
the main pancreatic duct enters the common bile duct, and 
the C-P type, where the CBD enters the main pancreatic 
duct [1]. The incidence of P-C type ductal junctions is high-
er in patients with GB cancer [4], while the incidence of C-P 
type junctions is higher in patients with carcinoma in con-
genital cystic dilatation [5]. In our experience, seven out of 
10 patients with gallbladder cancer associated with 
APBDU have the P-C type [6]. 
APBDU is frequently associated with choledochal cysts 
and the incidence of malignancy in choledochal cysts 
ranges from 2.5 to 26% [3]. The number of bile duct cancer 
cases exceeds the number of cases of gallbladder cancer in 
the dilated bile duct with APBDU. Gallbladder cancer fre-
quently occurs, but bile duct cancer also arises, in APBDU 
not associated with dilatation [7]. According to recent 
10-year data from the Japanese Study Group on Pancreati-
cobiliary Maljunction, however, the rate of gallbladder 
cancer is higher than bile duct cancer with biliary dilata-
tion [3]. The incidence of gallbladder cancer associated 
with APBDU is reported to range from 16.7 to 18.3% [4].
The gallbladder experiences conditions with signifi-
cantly greater malignant potential in patients with 
APBDU, especially in cases not associated with chol-
edochal cysts. Neoplastic development in the bile duct of 
patients with APBDU evolves through a multistep process 
associated with hyperproliferation and genetic alterations 
[3]. In our case, the K-ras mutation was not observed at any 
site of cancer. However, for epithelial cells in both cancer-
ous areas with positive Ki-67, it might have caused anoth-
er signal regulation apart from K-ras gene. 
Early resection of the cyst wall and bile duct with re-
construction of the biliary ducts is been recommended. To 
prevent biliary tract cancers, APBDU with cystic dilata-
tions should be excised during childhood. It is usually a 
surgical disease of infancy or childhood, but 20 to 30% of 
patients are first diagnosed in adulthood due to incidental 
findings during medical check-ups or late onset of symp-
toms [2]. In the present case, the patient had a choledochal 
cyst and APBDU without symptoms until her 60s. 
Although she was symptom-free, the congenital anoma-
lies of this patient eventually developed into biliary tract 
cancers of the gallbladder and CBD, both compatible with 
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stage IIIB according to the 7th American Joint Committee 
on Cancer tumor-node-metastasis classification system. 
Radical cholecystectomy, removal of the GB with en-bloc 
subsegmental resection of the adjacent hepatic paren-
chyma of segments IVb and V plus a regional lymphade-
nectomy, is suggested for T2 or more advanced GB cancer 
[8]. Surgeons who prefer aggressive operation often per-
form PPPD plus hepatectomy for GB cancer, and the hos-
pital mortalities of these cases were higher (10 to 15%) than 
those (2 to 5%) of PPPD or major hepatectomy [8]. 
Although the role of radiation therapy in patients with 
biliary malignancies remains a debate, favorable survivals 
have been reported in postoperative adjuvant radiation 
therapy for GB cancer with lymph node invasion [9]. 
Because simple cholecystectomy with external radio-
therapy can be recommended as an alternative treatments, 
only cholecystectomy with adjuvant chemoradiation ther-
apy performed for GB cancer in current report [10]. 
In conclusion, choledochal cysts and APBDU are closely 
associated biliary tract anomalies. The malignant poten-
tial of these disease entities usually requires early surgical 
intervention and life-long follow-up.
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